急性髓系白血病的体能状态评估:欧洲白血病网专家小组的建议
欧洲白血病网(ELN)专家小组针对急性髓系白血病(AML)患者的体能状态(fitness)评估提出建议:现有评分系统缺乏验证研究,尚无普遍接受的评估流程;体能评估应反映患者对某一具体治疗的适用性,而非仅对强化化疗是否适用的二元分类;评估框架应纳入生活质量、患者偏好、自报躯体与社会功能状态、社会支持及早期整合姑息治疗。
要点
- 体能评估应反映患者对具体治疗的适用性,而非对强化化疗的二元分类。
- 现有评分系统缺乏验证研究,尚无普遍接受的评估流程。
- 评估应纳入生活质量、患者偏好、自报功能状态、社会支持与早期姑息治疗。
核心结论
- 体能评估应超越传统临床和生物学疾病特征,纳入生活质量、患者偏好、患者自报躯体与社会功能状态、社会支持及早期整合姑息治疗。
- 现代解读下的体能评估是更大评估框架中的一部分,涵盖患者维持并从特定治疗方案中获益的整体能力。
研究设计与样本
- 欧洲白血病网(ELN)专家小组制定的建议(Blood Adv)。
主要发现
- 现有多种评分系统可用于辅助判定体能,但缺乏验证研究,导致缺乏普遍接受的评估流程。
- 新型药物不断增多、低强度治疗选择范围扩大,使体能评估过程更加复杂。
- 由于缺乏普遍接受的评估流程,体能评估的复杂性进一步增加。
关键数值与推荐
- 原文未报告具体评分阈值、验证数据或推荐等级。
- 体能评估应反映患者对多种可选治疗中某一具体治疗的适用性,而非对强化化疗适用性的通用二元分类。
临床怎么用
- 原文未据此给出具体可操作的推荐(原文为专家小组建议,未报告具体评估流程或评分阈值)。
局限性
- 原文指出尚无普遍接受的评估流程,原因是缺乏验证研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Fitness assessment in patients with acute myeloid leukemia (AML) is critical to deliver the right therapy to the right patient. Although several scoring systems are available to aid in determining fitness, the absence of validation studies has resulted in the lack of universally accepted assessment procedures. This limitation, combined with the increasing availability of novel agents expanding the spectrum of less-intensive options, has introduced additional complexity to the fitness assessment process. In this evolving context, fitness should reflect eligibility for a specific treatment among the several available, rather than a generic binary classification of eligibility for intensive chemotherapy. Moreover, the growing emphasis on patient-centered care, further highlights the importance of integrating quality of life, patient preferences, patient self-reported physical and social functioning status, social support, and early integration of palliative care into the assessment framework. A modern interpretation of fitness assessment should incorporate a comprehensive evaluation that extends beyond traditional clinical and biological disease characteristics. Thus, fitness assessment in patients with AML represents only 1 piece of a larger puzzle, encompassing the patient's overall capacity to sustain and benefit from a specific therapeutic program.
引用
- Venditti A, Palmieri R, Maurillo L, et al. Fitness assessment in acute myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet. Blood Adv. 2025. PMID: 39913928. doi:10.1182/bloodadvances.2024013744
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。